However, high expression of surface PD-L1 by solid tumours and tumour-infiltrating myeloid cells appears to be correlated with poor prognosis in certain cancers and may negatively impact the clinical response to PD-1 blockade [205]. The gene discussed is CD274; the disease is cancer.